Search This Blog

Sunday, January 13, 2019

Amarin: Potential Takeout, Positive Rx Trends Support Positive Thesis – Cantor


Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $35 price target on Amarin Corporation

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.